ALLO vs IEX · rev $4.6M vs P/E 29, rev $1.81B
Allogene Therapeutics Inc (ALLO) versus IDEX Corporation (IEX) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
IDEX Corporation (IEX) is a specialty industrial machinery company listed on US.
Latest reported ALLO revenue for 2026-06-30 was $4.6M. Net income was -$85.3M. ALLO currently screens at market cap $258.1M.
Latest reported IEX revenue for 2026-06-30 was $1.81B. Net income was $263.4M. IEX currently screens at market cap $13.71B and trailing P/E 28.8.
ALLO currently screens at market cap $258.1M. IEX currently screens at market cap $13.71B and trailing P/E 28.8.
Not investment advice. Open the ALLO and IEX stock pages for the full models.
Not investment advice.